Leffler, Daniel A.
Green, Peter H. R.
Fasano, Alessio
Article History
First Online: 11 August 2015
Competing interests
: D.A.L. has received funding from Alba Therapeutics, Alvine Pharmaceuticals, Coronado Bioscience, Inova diagnostics, Ironwood Pharmaceuticals, Sidney Frank Foundation and Shire Pharmaceuticals. P.H.R.G. has received funding from Alba Therapeutics, Alvine Pharmaceuticals and Immusan. A.F. has received funding from Alba Therapeutics, Inova diagnostics, Mead Johnson Nutrition and Pfizer Pharmaceutical.